Združene države Amerike - angleščina - NLM (National Library of Medicine)

washington homeopathic products - thyroidinum - to relieve the symptoms of headache. indications: thyroidinum   headache if symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

washington homeopathic products - thyroidinum - to relieve the symptoms of headache. indications: thyroidinum headache if symptoms persist/worsen or if pregnant/nursing, consult your practitioner.

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - taurolidine - nebuliser liquid - 20mg/1ml

Združene države Amerike - angleščina - NLM (National Library of Medicine)

cormedix inc. - taurolidine (unii: 8obz1m4v3v) (taurolidine - unii:8obz1m4v3v), heparin (unii: t2410km04a) (heparin - unii:t2410km04a) - limited population: defencath® is indicated to reduce the incidence of catheter-related bloodstream infections (crbsi) in adult patients with kidney failure receiving chronic hemodialysis (hd) through a central venous catheter (cvc). this drug is indicated for use in a limited and specific population of patients [see clinical studies (14)]. limitations of use the safety and effectiveness of defencath have not been established for use in populations other than adult patients with kidney failure receiving chronic hd through a cvc. defencath is contraindicated in patients with: - known heparin-induced thrombocytopenia (hit) [see warnings and precautions (5.1)] . - known hypersensitivity to taurolidine, heparin or the citrate excipient (components of defencath) or pork products [see warnings and precautions (5.2)]. risk summary defencath is not intended for systemic administration. it is intended for use as a cls in patients with kidney failure requiring chronic hd; therefore, maternal use is not expected to result in fetal exposure to the drug [see dosage and administration (2)] . no animal reproduction study was conducted with defencath. risk summary defencath is not intended for systemic administration. it is intended for use as a cls in patients with kidney failure requiring chronic hd; therefore, breastfeeding is not expected to result in exposure of the infant to defencath [see dosage and administration (2)] . the safety and effectiveness of defencath have not been established in pediatric patients. there are no available data on defencath use in pediatric patients. there were 327 patients 65 years of age and older in trial 1 [see clinical studies (14)] . of the total number of patients using defencath in this study, 162 (41%) were 65 years of age and older, while 64 (16%) were 75 years of age and older. no overall differences in safety or effectiveness were observed between patients 65 years of age and older and younger adult patients.

Irska - angleščina - HPRA (Health Products Regulatory Authority)

geistlich sons limited - taurolidine - solution for intraperitoneal lavage after dilution or solution for instillation - 2 percent weight/volume - antiinfectives; taurolidine

Irska - angleščina - HPRA (Health Products Regulatory Authority)

elara pharmaservices europe limited - taurolidine - intraperitoneal solution - 2 percent weight/volume - antiinfectives; taurolidine

Združene države Amerike - angleščina - NLM (National Library of Medicine)

seroyal usa - thyroid, unspecified (unii: 0b4fdl9i6p) (thyroid, unspecified - unii:0b4fdl9i6p) - thyroid, unspecified 6 [hp_x] - indications helps to maintain normal metabolic functions indications helps to maintain normal metabolic functions directions adults: take five granules three times daily or as recommended by your healthcare practitioner. children: take three granules and follow adult directions.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

boiron - thyroid, unspecified (unii: 0b4fdl9i6p) (thyroid, unspecified - unii:0b4fdl9i6p) - symptoms of eczema or psoriasis* stop use and ask a doctor if symptoms persist for more than 3 days or worsen

Združene države Amerike - angleščina - NLM (National Library of Medicine)

boiron - thyroid, unspecified (unii: 0b4fdl9i6p) (thyroid, unspecified - unii:0b4fdl9i6p) - symptoms of eczema or psoriasis* stop use and ask a doctor if symptoms persist for more than 3 days or worsen

Združene države Amerike - angleščina - NLM (National Library of Medicine)

boiron - thyroid, unspecified (unii: 0b4fdl9i6p) (thyroid, unspecified - unii:0b4fdl9i6p) - symptoms of eczema or psoriasis* stop use and ask a doctor if symptoms persist for more than 3 days or worsen